In Sik Shin

Mr. In Sik Shin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2012 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ISIn Sik Shin
In Sik Shin
MLMeeyoung Lee
Meeyoung Lee
HHHyekyung Ha
Hyekyung Ha
CSChangseob Seo
Changseob Seo
HSHyeun-Kyoo Shin
Hyeun-Kyoo Shin
Yukmijihwang-tang, a traditional herbal formula, has been used for treating disorder, diabetic mellitus and neurosis in China (Liu-wei-di-huang-tang in Chinese), Japan (Lokumijio-to in Japanese) and Korea for many years. In this study, we investigated the effects of Yukmijihwang-tang water extract (YJT) on the development of benign prostatic hyperplasia (BPH) using a rat model of testosterone propionate (TP)-induced BPH.

1 January 2012 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
ISIn Sik Shin
In Sik Shin
MLMeeyoung Lee
Meeyoung Lee
HHHyekyung Ha
Hyekyung Ha
WJWoo-Young Jeon
Woo-Young Jeon
CSChangseob Seo
Changseob Seo
HSHyeun-Kyoo Shin
Hyeun-Kyoo Shin
Dianthus superbus has long been used as a herbal medicine in Asia and as an anti-inflammatory agent. In this study, we evaluated the anti-inflammatory effects of Dianthus superbus fructus ethanolic extract (DSE) on Th2-type cytokines, eosinophil infiltration, and other factors in an ovalbumin (OVA)-induced murine asthma model. To study the possible mechanism of the anti-inflammatory effect of DSE, we also evaluated the expression of inducible nitric oxide synthase (iNOS) in the respiratory tract.

17 December 2012 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MLMee Young Lee
Mee Young Lee
ISIn Sik Shin
In Sik Shin
HLHye-Sun Lim
Hye-Sun Lim
HSHyeun-Kyoo Shin
Hyeun-Kyoo Shin
Background: In this study, we investigated the effect of Samchulkunbi-tang water extract (SCTE) in an established mouse model of ovalbumin (OVA)-induced allergic asthma. The effects of SCTE on the production of Th1 and Th2 cytokines, eotaxin, and total and OVA-specific immunoglobulin E, inducible nitric oxide synthase expression, and matrix metalloproteinase-9 activity were measured. Methods: Mice were sensitized on days 0 and 14 with an intraperitoneal injection of 20 μg ovalbumin (OVA) emulsified in 2 mg aluminum hydroxide in 200 μL PBS buffer. On days 21, 22, and 23, mice received an airway exposure to OVA (1%, w/v, in PBS) for 1 h. SCTE was administered orally to mice at doses of 200 and 400 mg/kg per day from days 18 to 23. Results: SCTE reduced the number of inflammatory cells, cytokines, and chemokines in bronchoalveolar lavage fluids and iNOS expression and MMP-9 activity in mouse lung tissue. Histological studies using hematoxylin & eosin and periodic acid-schiff staining showed that SCTE substantially inhibited OVA-induced inflammatory cell infiltration in lung tissue and goblet cell hyperplasia in the airway. SCTE also reduced IL-4 and IL-13 expression in concanavalin-A-stimulated splenocytes. These results were similar to those obtained with montelukast as a positive control. Conclusions: Collectively, these results suggest that SCTE may be an effective oral treatment for allergic airway inflammation by virtue of its anti-inflammatory activity.